Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2017 Feb 28;55(3):172–182. doi: 10.1007/s12275-017-7026-y

The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic

Jasper F W Chan 1,2,3,4, Siddharth Sridhar 2, Cyril C Y Yip 2, Susanna K P Lau 1,2,3,4, Patrick C Y Woo 1,2,3,4,✉
PMCID: PMC7090747  PMID: 28243939

Abstract

Rapidly emerging infectious disease outbreaks place a great strain on laboratories to develop and implement sensitive and specific diagnostic tests for patient management and infection control in a timely manner. Furthermore, laboratories also play a role in real-time zoonotic, environmental, and epidemiological investigations to identify the ultimate source of the epidemic, facilitating measures to eventually control the outbreak. Each assay modality has unique pros and cons; therefore, incorporation of a battery of tests using traditional culture-based, molecular and serological diagnostics into diagnostic algorithms is often required. As such, laboratories face challenges in assay development, test evaluation, and subsequent quality assurance. In this review, we describe the different testing modalities available for the ongoing Middle East respiratory syndrome (MERS) epidemic including cell culture, nucleic acid amplification, antigen detection, and antibody detection assays. Applications of such tests in both acute clinical and epidemiological investigation settings are highlighted. Using the MERS epidemic as an example, we illustrate the various challenges faced by laboratories in test development and implementation in the setting of a rapidly emerging infectious disease. Future directions in the diagnosis of MERS and other emerging infectious disease investigations are also highlighted.

Keywords: coronavirus, middle east, MERS, diagnosis, epidemic

Footnotes

These authors contributed equally to this work.

References

  1. Abd El Wahed, A., Patel, P., Heidenreich, D., Hufert, F.T., and Weidmann, M. 2013. Reverse transcription recombinase polymerase amplification assay for the detection of middle East respiratory syndrome coronavirus. PLoS Curr. 5, DOI: 10.1371/currents. outbreaks.62df1c7c75ffc96cd59034531e2e8364. [DOI] [PMC free article] [PubMed]
  2. Abroug F., Slim A., Ouanes-Besbes L., Hadj Kacem M.A., Dachraoui F., Ouanes I., Lu X., Tao Y., Paden C., Caidi H., et al. Family cluster of Middle East respiratory syndrome coronavirus infections, Tunisia, 2013. Emerg. Infect. Dis. 2014;20:1527–1530. doi: 10.3201/eid2009.140378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aburizaiza A.S., Mattes F.M., Azhar E.I., Hassan A.M., Memish Z.A., Muth D., Meyer B., Lattwein E., Muller M.A., Drosten C. Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J. Infect. Dis. 2014;209:243–246. doi: 10.1093/infdis/jit589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Agrawal A.S., Garron T., Tao X., Peng B.H., Wakamiya M., Chan T.S., Couch R.B., Tseng C.T. Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J. Virol. 2015;89:3659–3670. doi: 10.1128/JVI.03427-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Alagaili A.N., Briese T., Mishra N., Kapoor V., Sameroff S.C., Burbelo P.D., de Wit E., Munster V.J., Hensley L.E., Zalmout I.S., et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio. 2014;5:00884. doi: 10.1128/mBio.00884-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Arabi Y.M., Harthi A., Hussein J., Bouchama A., Johani S., Hajeer A.H., Saeed B.T., Wahbi A., Saedy A., AlDabbagh T., et al. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) Infection. 2015;43:495–501. doi: 10.1007/s15010-015-0720-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., Al-Rabiah F.A. A.-, Hajjar S., Al-Barrak A., Flemban H., Al-Nassir W.N., Balkhy H.H., Al-Hakeem R.F., et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 2013;13:752–761. doi: 10.1016/S1473-3099(13)70204-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Assiri A., McGeer A., Perl T.M., Price C.S. A., Rabeeah A.A., Cummings D.A., Alabdullatif Z.N., Assad M., Almulhim A., Makhdoom H., et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N. Engl. J. Med. 2013;369:407–416. doi: 10.1056/NEJMoa1306742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bhadra S., Jiang Y.S., Kumar M.R., Johnson R.F., Hensley L.E., Ellington A.D. Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV) PLoS One. 2015;10:0123126. doi: 10.1371/journal.pone.0123126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Buchholz, U., Muller, M.A., Nitsche, A., Sanewski, A., Wevering, N., Bauer-Balci, T., Bonin, F., Drosten, C., Schweiger, B., Wolff, T., et al. 2013. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill. 18, pii: 20406. [PubMed]
  11. Chan J.F., Chan K.H., Choi G.K., To K.K., Tse H., Cai J.P., Yeung M.L., Cheng V.C., Chen H., Che X.Y., et al. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J. Infect. Dis. 2013;207:1743–1752. doi: 10.1093/infdis/jit123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chan J.F., Chan K.H., Kao R.Y., To K.K., Zheng B.J., Li C.P., Li P.T., Dai J., Mok F.K., Chen H., et al. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J. Infect. 2013;67:606–616. doi: 10.1016/j.jinf.2013.09.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chan J.F., Choi G.K., Tsang A.K., Tee K.M., Lam H.Y., Yip C.C., To K.K., Cheng V.C., Yeung M.L., Lau S.K., et al. Development and evaluation of novel real-time reverse transcription-PCR assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses. J. Clin. Microbiol. 2015;53:2722–2726. doi: 10.1128/JCM.01224-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Chan J.F., Choi G.K., Yip C.C., Cheng V.C., Yuen K.Y. Zika fever and congenital Zika syndrome: An unexpected emerging arboviral disease. J. Infect. 2016;72:507–524. doi: 10.1016/j.jinf.2016.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chan J.F., Lau S.K., To K.K., Cheng V.C., Woo P.C., Yuen K.Y. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin. Microbiol. Rev. 2015;28:465–522. doi: 10.1128/CMR.00102-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Chan J.F., Lau S.K., Woo P.C. The emerging novel Middle East respiratory syndrome coronavirus: the “knowns” and “unknowns”. J. Formos. Med. Assoc. 2013;112:372–381. doi: 10.1016/j.jfma.2013.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Chan J.F., Li K.S., To K.K., Cheng V.C., Chen H., Yuen K.Y. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J. Infect. 2012;65:477–489. doi: 10.1016/j.jinf.2012.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chan J.F., To K.K., Chen H., Yuen K.Y. Cross-species transmission and emergence of novel viruses from birds. Curr. Opin. Virol. 2015;10:63–69. doi: 10.1016/j.coviro.2015.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chan J.F., To K.K., Tse H., Jin D.Y., Yuen K.Y. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol. 2013;21:544–555. doi: 10.1016/j.tim.2013.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Chan J.F., Yao Y., Yeung M.L., Deng W., Bao L., Jia L., Li F., Xiao C., Gao H., Yu P., et al. Treatment with lopinavir/ ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J. Infect. Dis. 2015;212:1904–1913. doi: 10.1093/infdis/jiv392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Chan K.H., Chan J.F., Tse H., Chen H., Lau C.C., Cai J.P., Tsang A.K., Xiao X., To K.K., Lau S.K., et al. Cross-reactive antibodies in convalescent SARS patients’ sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests. J. Infect. 2013;67:130–140. doi: 10.1016/j.jinf.2013.03.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Chan K.H., Maldeis N., Pope W., Yup A., Ozinskas A., Gill J., Seto W.H., Shortridge K.F., Peiris J.S. Evaluation of the Directigen FluA+B test for rapid diagnosis of influenza virus type A and B infections. J. Clin. Microbiol. 2002;40:1675–1680. doi: 10.1128/JCM.40.5.1675-1680.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Chan K.H., Poon L.L., Cheng V.C., Guan Y., Hung I.F., Kong J., Yam L.Y., Seto W.H., Yuen K.Y., Peiris J.S. Detection of SARS coronavirus in patients with suspected SARS. Emerg. Infect. Dis. 2004;10:294–299. doi: 10.3201/eid1002.030610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Chan, R.W., Chan, M.C., Agnihothram, S., Chan, L.L., Kuok, D.I., Fong, J.H., Guan, Y., Poon, L.L., Baric, R.S., Nicholls, J.M., et al. 2013f. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J. Virol. 87, 6604–6614. [DOI] [PMC free article] [PubMed]
  25. Chen Y., Chan K.H., Hong C., Kang Y., Ge S., Chen H., Wong E.Y., Joseph S., Patteril N.G., Wernery U., et al. A highly specific rapid antigen detection assay for on-site diagnosis of MERS. J. Infect. 2016;73:82–84. doi: 10.1016/j.jinf.2016.04.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Chen Y., Chan K.H., Kang Y., Chen H., Luk H.K., Poon R.W., Chan J.F., Yuen K.Y., Xia N., Lau S.K., et al. A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus. Emerg. Microbes Infect. 2015;4:26. doi: 10.1038/emi.2015.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Cho S.Y., Kang J.M., Ha Y.E., Park G.E., Lee J.Y., Ko J.H., Lee J.Y., Kim J.M., Kang C.I., Jo I.J., et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet. 2016;388:994–1001. doi: 10.1016/S0140-6736(16)30623-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Chu H., Zhou J., Wong B.H., Li C., Chan J.F., Cheng Z.S., Yang D., Wang D., Lee A.C., Li C., et al. Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J. Infect. Dis. 2016;213:904–914. doi: 10.1093/infdis/jiv380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Chu, H., Zhou, J., Wong, B.H., Li, C., Cheng, Z.S., Lin, X., Poon, V.K., Sun, T., Lau, C.C., Chan, J.F., et al. 2014. Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology 454-455, 197–205. [DOI] [PMC free article] [PubMed]
  30. Coleman C.M., Matthews K.L., Goicochea L., Frieman M.B. Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus. J. Gen. Virol. 2014;95:408–412. doi: 10.1099/vir.0.060640-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Corman V.M., Albarrak A.M., Omrani A.S., Albarrak M.M., Farah M.E., Almasri M., Muth D., Sieberg A., Meyer B., Assiri A.M., et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin. Infect. Dis. 2016;62:477–483. doi: 10.1093/cid/civ951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Corman, V.M., Eckerle, I., Bleicker, T., Zaki, A., Landt, O., Eschbach- Bludau, M., van Boheemen, S., Gopal, R., Ballhause, M., Bestebroer, T.M., et al. 2012a. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 17, pii: 20285. [DOI] [PubMed]
  33. Corman, V.M., Muller, M.A., Costabel, U., Timm, J., Binger, T., Meyer, B., Kreher, P., Lattwein, E., Eschbach-Bludau, M., Nitsche, A., et al. 2012b. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 17, pii: 20334. [DOI] [PubMed]
  34. Corman V.M., Olschlager S., Wendtner C.M., Drexler J.F., Hess M., Drosten C. Performance and clinical validation of the RealStar MERS-CoV kit for detection of Middle East respiratory syndrome coronavirus RNA. J. Clin. Virol. 2014;60:168–171. doi: 10.1016/j.jcv.2014.03.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. de Wilde A.H., Jochmans D., Posthuma C.C., Zevenhoven-Dobbe J.C., van Nieuwkoop S., Bestebroer T.M. v. d., Hoogen B.G., Neyts J., Snijder E.J. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob. Agents Chemother. 2014;58:4875–4884. doi: 10.1128/AAC.03011-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. de Wilde A.H., Raj V.S., Oudshoorn D., Bestebroer T.M., van Nieuwkoop S., Limpens R.W., Posthuma C.C., van der Meer Y., Barcena M., Haagmans B.L., et al. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment. J. Gen. Virol. 2013;94:1749–1760. doi: 10.1099/vir.0.052910-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. de Wit E., Prescott J., Baseler L., Bushmaker T., Thomas T., Lackemeyer M.G., Martellaro C., Milne-Price S., Haddock E., Haagmans B.L., et al. The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters. PLoS One. 2013;8:69127. doi: 10.1371/journal.pone.0069127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. de Wit E., Rasmussen A.L., Falzarano D., Bushmaker T., Feldmann F., Brining D.L., Fischer E.R., Martellaro C., Okumura A., Chang J., et al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc. Natl. Acad. Sci. USA. 2013;110:16598–16603. doi: 10.1073/pnas.1310744110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Douglas C.E., Kulesh D.A., Jaissle J.G., Minogue T.D. Real-time reverse transcriptase polymerase chain reaction assays for Middle East Respiratory Syndrome. Mol. Cell Probes. 2015;29:511–513. doi: 10.1016/j.mcp.2015.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Drosten C., Meyer B., Muller M.A., Corman V.M., Al-Masri M., Hossain R., Madani H., Sieberg A., Bosch B.J., Lattwein E., et al. Transmission of MERS-coronavirus in household contacts. N. Engl. J. Med. 2014;371:828–835. doi: 10.1056/NEJMoa1405858. [DOI] [PubMed] [Google Scholar]
  41. Drosten C., Seilmaier M., Corman V.M., Hartmann W., Scheible G., Sack S., Guggemos W., Kallies R., Muth D., Junglen S., et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect. Dis. 2013;13:745–751. doi: 10.1016/S1473-3099(13)70154-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Dyall J., Coleman C.M., Hart B.J., Venkataraman T., Holbrook M.R., Kindrachuk J., Johnson R.F., Olinger G.G., Jahrling P.B., Laidlaw M., et al. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob. Agents Chemother. 2014;58:4885–4893. doi: 10.1128/AAC.03036-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Eckerle I., Corman V.M., Muller M.A., Lenk M., Ulrich R.G., Drosten C. Replicative capacity of MERS coronavirus in livestock cell lines. Emerg. Infect. Dis. 2014;20:276–279. doi: 10.3201/eid2002.131182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Falzarano D., de Wit E., Feldmann F., Rasmussen A.L., Okumura A., Peng X., Thomas M.J., van Doremalen N., Haddock E., Nagy L., et al. Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog. 2014;10:1004250. doi: 10.1371/journal.ppat.1004250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Gao J., Lu G., Qi J., Li Y., Wu Y., Deng Y., Geng H., Li H., Wang Q., Xiao H., et al. Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J. Virol. 2013;87:13134–13140. doi: 10.1128/JVI.02433-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Glushakova L.G., Sharma N., Hoshika S., Bradley A.C., Bradley K.M., Yang Z., Benner S.A. Detecting respiratory viral RNA using expanded genetic alphabets and self-avoiding DNA. Anal. Biochem. 2015;489:62–72. doi: 10.1016/j.ab.2015.08.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Guan M., Chen H.Y., Tan P.H., Shen S., Goh P.Y., Tan Y.J., Pang P.H., Lu Y., Fong P.Y., Chin D. Use of viral lysate antigen combined with recombinant protein in Western immunoblot assay as confirmatory test for serodiagnosis of severe acute respiratory syndrome. Clin. Diagn. Lab. Immunol. 2004;11:1148–1153. doi: 10.1128/CDLI.11.6.1148-1153.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Guery B., Poissy J. e., Mansouf L., Sejourne C., Ettahar N., Lemaire X., Vuotto F., Goffard A., Behillil S., Enouf V., et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013;381:2265–2272. doi: 10.1016/S0140-6736(13)60982-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Haagmans B.L. A., Dhahiry S.H., Reusken C.B., Raj V.S., Galiano M., Myers R., Godeke G.J., Jonges M., Farag E., Diab A., et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect. Dis. 2014;14:140–145. doi: 10.1016/S1473-3099(13)70690-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Haagmans B.L. v. d., Brand J.M., Provacia L.B., Raj V.S., Stittelaar K.J., Getu S., de Waal L., Bestebroer T.M., van Amerongen G., Verjans G.M., et al. Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits. J. Virol. 2015;89:6131–6135. doi: 10.1128/JVI.00661-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Jiang L., Wang N., Zuo T., Shi X., Poon K.M., Wu Y., Gao F., Li D., Wang R., Guo J., et al. Potent neutralization of MERSCoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci. Transl. Med. 2014;6:234. doi: 10.1126/scitranslmed.3008140. [DOI] [PubMed] [Google Scholar]
  52. Kim C.J., Choi W.S., Jung Y., Kiem S., Seol H.Y., Woo H.J., Choi Y.H., Son J.S., Kim K.H., Kim Y.S., et al. Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity. Clin. Microbiol. Infect. 2016;22:880–886. doi: 10.1016/j.cmi.2016.07.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Kim M.N., Ko Y.J., Seong M.W., Kim J.S., Shin B.M., Sung H. Analytical and clinical validation of six commercial Middle East respiratory syndrome coronavirus RNA Detection kits based on real-time reverse-transcription PCR. Ann. Lab. Med. 2016;36:450–456. doi: 10.3343/alm.2016.36.5.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Kim S.Y., Park S.J., Cho S.Y., Cha R.H., Jee H.G., Kim G., Shin H.S., Kim Y., Jung Y.M., Yang J.S., et al. Viral RNA in blood as indicator of severe outcome in Middle East respiratory syndrome coronavirus infection. Emerg. Infect. Dis. 2016;22:1813–1816. doi: 10.3201/eid2210.160218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Lau S.K., Lau C.C., Chan K.H., Li C.P., Chen H., Jin D.Y., Chan J.F., Woo P.C., Yuen K.Y. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J. Gen. Virol. 2013;94:2679–2690. doi: 10.1099/vir.0.055533-0. [DOI] [PubMed] [Google Scholar]
  56. Lau S.K., Li K.S., Tsang A.K., Lam C.S., Ahmed S., Chen H., Chan K.H., Woo P.C., Yuen K.Y. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J. Virol. 2013;87:8638–8650. doi: 10.1128/JVI.01055-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Lau S.K., Wernery R., Wong E.Y., Joseph S., Tsang A.K., Patteril N.A., Elizabeth S.K., Chan K.H., Muhammed R., Kinne J., et al. Polyphyletic origin of MERS coronaviruses and isolation of a novel clade A strain from dromedary camels in the United Arab Emirates. Emerg. Microbes Infect. 2016;5:128. doi: 10.1038/emi.2016.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Lu L., Liu Q., Zhu Y., Chan K.H., Qin L., Li Y., Wang Q., Chan J.F., Du L., Yu F., et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat. Commun. 2014;5:3067. doi: 10.1038/ncomms4067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Lu X., Whitaker B., Sakthivel S.K., Kamili S., Rose L.E., Lowe L., Mohareb E., Elassal E.M., Al-sanouri T., Haddadin A., et al. Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus. J. Clin. Microbiol. 2014;52:67–75. doi: 10.1128/JCM.02533-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Memish Z.A., Al-Tawfiq J.A., Assiri A., AlRabiah F.A. A., Hajjar S., Albarrak A., Flemban H., Alhakeem R.F., Makhdoom H.Q., Alsubaie S., et al. Middle East respiratory syndrome coronavirus disease in children. Pediatr. Infect. Dis. J. 2014;33:904–906. doi: 10.1097/INF.0000000000000325. [DOI] [PubMed] [Google Scholar]
  61. Memish Z.A., Al-Tawfiq J.A., Makhdoom H.Q., Assiri A., Alhakeem R.F., Albarrak A., Alsubaie S., Al-Rabeeah A.A., Hajomar W.H., Hussain R., et al. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J. Infect. Dis. 2014;210:1590–1594. doi: 10.1093/infdis/jiu292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Memish Z.A., Zumla A.I., Assiri A. Middle East respiratory syndrome coronavirus infections in health care workers. N. Engl. J. Med. 2013;369:884–886. doi: 10.1056/NEJMc1308698. [DOI] [PubMed] [Google Scholar]
  63. Meyer B., Drosten C., Muller M.A. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 2014;194:175–183. doi: 10.1016/j.virusres.2014.03.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Meyer B., Muller M.A., Corman V.M., Reusken C.B., Ritz D., Godeke G.J., Lattwein E., Kallies S., Siemens A., van Beek J., et al. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg. Infect. Dis. 2014;20:552–559. doi: 10.3201/eid2004.131746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Muller M.A., Meyer B., Corman V.M., Al-Masri M., Turkestani A., Ritz D., Sieberg A., Aldabbagh S., Bosch B.J., Lattwein E., et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect. Dis. 2015;15:559–564. doi: 10.1016/S1473-3099(15)70090-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Muller, M.A., Raj, V.S., Muth, D., Meyer, B., Kallies, S., Smits, S.L., Wollny, R., Bestebroer, T.M., Specht, S., Suliman, T., et al. 2012. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio 3, pii: e00515-12. [DOI] [PMC free article] [PubMed]
  67. Munster V.J., de Wit E., Feldmann H. Pneumonia from human coronavirus in a macaque model. N. Engl. J. Med. 2013;368:1560–1562. doi: 10.1056/NEJMc1215691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Muth D., Corman V.M., Meyer B., Assiri A., Al-Masri M., Farah M., Steinhagen K., Lattwein E., Al-Tawfiq J.A., Albarrak A., et al. Infectious Middle East respiratory syndrome coronavirus excretion and serotype variability based on live virus isolates from patients in Saudi Arabia. J. Clin. Microbiol. 2015;53:2951–2955. doi: 10.1128/JCM.01368-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Oboho I.K., Tomczyk S.M., Al-Asmari A.M., Banjar A.A. A.-, Mugti H., Aloraini M.S., Alkhaldi K.Z., Almohammadi E.L., Alraddadi B.M., Gerber S.I., et al. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. N. Engl. J. Med. 2015;372:846–854. doi: 10.1056/NEJMoa1408636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Oh M.D., Park W.B., Choe P.G., Choi S.J., Kim J.I., Chae J., Park S.S., Kim E.C., Oh H.S., Kim E.J., et al. Viral load kinetics of MERS coronavirus infection. N. Engl. J. Med. 2016;375:1303–1305. doi: 10.1056/NEJMc1511695. [DOI] [PubMed] [Google Scholar]
  71. Omrani A.S., Matin M.A., Haddad Q., Al-Nakhli D., Memish Z.A., Albarrak A.M. A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int. J. Infect. Dis. 2013;17:668. doi: 10.1016/j.ijid.2013.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Palm, D., Pereyaslov D., Vaz, J., Broberg, E., Zeller, H., Gross, D., Brown, C.S., Struelens, M.J., Joint ECDC-WHO Regional Office for Europe Novel Coronavirus Laboratory Survey participants, ECDC National Microbiology Focal Points, et al. 2012. Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012. Euro Surveill. 17, pii: 20335. [DOI] [PubMed]
  73. Park, S.W., Perera, R.A., Choe, P.G., Lau, E.H., Choi, S.J., Chun, J.Y., Oh, H.S., Song, K.H., Bang, J.H., Kim, E.S., et al. 2015a. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection. Euro Surveill. 20, pii= 30042. [DOI] [PubMed]
  74. Park W.B., Perera R.A., Choe P.G., Lau E.H., Choi S.J., Chun J.Y., Oh H.S., Song K.H., Bang J.H., Kim E.S., et al. Kinetics of serologic responses to MERS Coronavirus infection in humans, South Korea. Emerg. Infect. Dis. 2015;21:2186–2189. doi: 10.3201/eid2112.151421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Pas S.D., Patel P., Reusken C., Domingo C., Corman V.M., Drosten C., Dijkman R., Thiel V., Nowotny N., Koopmans M.P., et al. First international external quality assessment of molecular diagnostics for Mers-CoV. J. Clin. Virol. 2015;69:81–85. doi: 10.1016/j.jcv.2015.05.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Payne D.C., Iblan I., Rha B., Alqasrawi S., Haddadin A. A., Nsour M., Alsanouri T., Ali S.S., Harcourt J., Miao C., et al. Persistence of antibodies against Middle East respiratory syndrome coronavirus. Emerg. Infect. Dis. 2016;22:1824–1826. doi: 10.3201/eid2210.160706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Perera, R.A., Wang, P., Gomaa, M.R., El-Shesheny, R., Kandeil, A., Bagato, O., Siu, L.Y., Shehata, M.M., Kayed, A.S., Moatasim, Y., et al. 2013. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 18, pii=20574. [DOI] [PubMed]
  78. Poissy J., Goffard A., Parmentier-Decrucq E., Favory R., Kauv M., Kipnis E., Mathieu D., van der Werf S., Guery B.,M. E.-C. B. G.r.o.u.p. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J. Clin. Virol. 2014;61:275–278. doi: 10.1016/j.jcv.2014.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Reusken C.B., Haagmans B.L., Muller M.A., Gutierrez C., Godeke G.J., Meyer B., Muth D., Raj V.S. S.-, de Vries L., Corman V.M., et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect. Dis. 2013;13:859–866. doi: 10.1016/S1473-3099(13)70164-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Reusken C., Mou H., Godeke G.J., van der Hoek L., Meyer B., Muller M.A., Haagmans B., de Sousa R., Schuurman N., Dittmer U., et al. Specific serology for emerging human coronaviruses by protein microarray. Euro Surveill. 2013;18:20441. doi: 10.2807/1560-7917.ES2013.18.14.20441. [DOI] [PubMed] [Google Scholar]
  81. Scheuplein V.A., Seifried J., Malczyk A.H., Miller L., Hocker L., Vergara-Alert J., Dolnik O., Zielecki F., Becker B., Spreitzer I., et al. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. J. Virol. 2015;89:3859–3869. doi: 10.1128/JVI.03607-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Seong M.W., Lee S.J., Cho S.I., Ko K., Kim M.N., Sung H., Kim J.S., Ahn J.S., Yu B.S., Kim T.S., et al. External quality assessment of MERS-CoV molecular diagnostics during the 2015 Korean Outbreak. Ann. Lab. Med. 2016;36:230–234. doi: 10.3343/alm.2016.36.3.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Shirato K., Yano T., Senba S., Akachi S., Kobayashi T., Nishinaka T., Notomi T., Matsuyama S. Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP) Virol. J. 2014;11:139. doi: 10.1186/1743-422X-11-139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Song D., Ha G., Serhan W., Eltahir Y., Yusof M., Hashem F., Elsayed E., Marzoug B., Abdelazim A., Al Muhairi S. Development and validation of a rapid immunochromatographic assay for detection of Middle East respiratory syndrome coronavirus antigen in dromedary camels. J. Clin. Microbiol. 2015;53:1178–1182. doi: 10.1128/JCM.03096-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Sridhar S., To K.K., Chan J.F., Lau S.K., Woo P.C., Yuen K.Y. A systematic approach to novel virus discovery in emerging infectious disease outbreaks. J. Mol. Diagn. 2015;17:230–241. doi: 10.1016/j.jmoldx.2014.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Sung H., Yong D., Ki C.S., Kim J.S., Seong M.W., Lee H., Kim M.N. Comparative evaluation of three homogenization methods for isolating Middle East respiratory syndrome coronavirus nucleic acids from sputum samples for real-time reverse transcription PCR. Ann. Lab. Med. 2016;36:457–462. doi: 10.3343/alm.2016.36.5.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Tang X.C., Agnihothram S.S., Jiao Y., Stanhope J., Graham R.L., Peterson E.C., Avnir Y., Tallarico A.S., Sheehan J., Zhu Q., et al. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution. Proc. Natl. Acad. Sci. USA. 2014;111:2018. doi: 10.1073/pnas.1402074111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. To K.K., Chan J.F., Chen H., Li L., Yuen K.Y. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect. Dis. 2013;13:809–821. doi: 10.1016/S1473-3099(13)70167-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. To K.K., Chan J.F., Tsang A.K., Cheng V.C., Yuen K.Y. Ebola virus disease: a highly fatal infectious disease reemerging in West Africa. Microbes Infect. 2015;17:84–97. doi: 10.1016/j.micinf.2014.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. To K.K., Tsang A.K., Chan J.F., Cheng V.C., Chen H., Yuen K.Y. Emergence in China of human disease due to avian influenza A(H10N8)–cause for concern? J. Infect. 2014;68:205–215. doi: 10.1016/j.jinf.2013.12.014. [DOI] [PubMed] [Google Scholar]
  91. Tynell J., Westenius V., Ronkko E., Munster V.J., Melen K., Osterlund P., Julkunen I. Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells. J. Gen. Virol. 2016;97:344–355. doi: 10.1099/jgv.0.000351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Uyeki, T.M., Erlandson, K.J., Korch, G., O’Hara, M., Wathen, M., Hu-Primmer, J., Hojvat, S., Stemmy, E.J., and Donabedian, A. 2016. Development of medical countermeasures to Middle East respiratory syndrome coronavirus. Emerg. Infect. Dis. 22, DOI: 10.3201/eid2207.160022. [DOI] [PMC free article] [PubMed]
  93. Wang Q., Qi J., Yuan Y., Xuan Y., Han P., Wan Y., Ji W., Li Y., Wu Y., Wang J., et al. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe. 2014;16:328–337. doi: 10.1016/j.chom.2014.08.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Wang W., Wang H., Deng Y., Song T., Lan J., Wu G., Ke C., Tan W. Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China. Emerg. Microbes Infect. 2016;5:113. doi: 10.1038/emi.2016.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Wang W.L., Wang H.J., Deng Y., Song T., Lan J.M., Wu G.Z., Ke C.W., Tan W.J. Serological study of an imported case of Middle East respiratory syndrome and his close contacts in China, 2015. Biomed. Environ. Sci. 2016;29:219–223. doi: 10.3967/bes2016.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Wernery U. E., Rasoul I.H., Wong E.Y., Joseph M., Chen Y., Jose S., Tsang A.K., Patteril N.A., Chen H., Elizabeth S.K., et al. A phylogenetically distinct Middle East respiratory syndrome coronavirus detected in a dromedary calf from a closed dairy herd in Dubai with rising seroprevalence with age. Emerg. Microbes Infect. 2015;4:74. doi: 10.1038/emi.2015.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Woo P.C., Lau S.K., Li K.S., Tsang A.K., Yuen K.Y. Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5. Emerg. Microbes Infect. 2012;1:35. doi: 10.1038/emi.2012.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Woo P.C., Lau S.K., Wong B.H., Chan K.H., Chu C.M., Tsoi H.W., Huang Y., Peiris J.S., Yuen K.Y. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin. Diagn. Lab. Immunol. 2004;11:665–668. doi: 10.1128/CDLI.11.4.665-668.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Woo P.C., Lau S.K., Wong B.H., Tsoi H.W., Fung A.M., Kao R.Y., Chan K.H., Peiris J.S., Yuen K.Y. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J. Clin. Microbiol. 2005;43:3054–3058. doi: 10.1128/JCM.43.7.3054-3058.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Yamaoka Y., Matsuyama S., Fukushi S., Matsunaga S., Matsushima Y., Kuroyama H., Kimura H., Takeda M., Chimuro T., Ryo A. Development of monoclonal antibody and diagnostic test for Middle East respiratory syndrome coronavirus using cell-free synthesized nucleocapsid antigen. Front. Microbiol. 2016;7:509. doi: 10.3389/fmicb.2016.00509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Yao Y., Bao L., Deng W., Xu L., Li F., Lv Q., Yu P., Chen T., Xu Y., Zhu H., et al. An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. J. Infect. Dis. 2014;209:236–242. doi: 10.1093/infdis/jit590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Yaren O., Glushakova L.G., Bradley K.M., Hoshika S., Benner S.A. Standard and AEGIS nicking molecular beacons detect amplicons from the Middle East respiratory syndrome coronavirus. J. Virol. Methods. 2016;236:54–61. doi: 10.1016/j.jviromet.2016.07.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Yeung M.L., Yao Y., Jia L., Chan J.F., Chan K.H., Cheung K.F., Chen H., Poon V.K., Tsang A.K., To K.K., et al. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat. Microbiol. 2016;1:16004. doi: 10.1038/nmicrobiol.2016.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Ying T., Du L., Ju T.W., Prabakaran P., Lau C.C., Lu L., Liu Q., Wang L., Feng Y., Wang Y., et al. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J. Virol. 2014;88:7796–7805. doi: 10.1128/JVI.00912-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012;367:1814–1820. doi: 10.1056/NEJMoa1211721. [DOI] [PubMed] [Google Scholar]
  106. Zhang L., Hao M., Zhang K., Zhang R., Lin G., Jia T., Zhang D., Chang L., Xie J., Li J. External quality assessment for the molecular detection of MERS-CoV in China. J. Clin. Virol. 2016;75:5–9. doi: 10.1016/j.jcv.2015.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Zhao J., Li K., Wohlford-Lenane C., Agnihothram S.S., Fett C., Zhao J., Gale M.J., Baric R.S.J.r., Enjuanes L., Gallagher T., et al. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc. Natl. Acad. Sci. USA. 2014;111:4970–4975. doi: 10.1073/pnas.1323279111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Zhou J., Chu H., Chan J.F., Yuen K.Y. Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis. Virol. J. 2015;12:218. doi: 10.1186/s12985-015-0446-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Zhou J., Chu H., Li C., Wong B.H., Cheng Z.S., Poon V.K., Sun T., Lau C.C., Wong K.K., Chan J.Y., et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J. Infect. Dis. 2014;209:1331–1342. doi: 10.1093/infdis/jit504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Zumla A., Chan J.F., Azhar E.I., Hui D.S., Yuen K.Y. Coronaviruses–drug discovery and therapeutic options. Nat. Rev. Drug. Discov. 2016;15:327–347. doi: 10.1038/nrd.2015.37. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Microbiology (Seoul, Korea) are provided here courtesy of Nature Publishing Group

RESOURCES